Many investors appreciate the pharmaceutical manufacturer industry for its potential to produce both income and long-term growth. Several large-cap drug makers offer above-average yields, and have records of growing their business and payouts over the long term. Additionally, historically many drug-makers have acted resiliently during previous economic downturns and recessions.
These companies are often considered defensive stocks. They still can go down, and most recently did, but many believe that this industry currently represents a strong long-term value. Also, several large pharmaceutical companies will continue to pay substantial dividends, benefit from emerging market growth and continue to develop new medical advancements. Further, medical price increases tend to outpace inflation.
Source: Seeking Alpha
Related Articles:
- 3 Styles Of Sucessful Dividend Investing
- 9 Small/Mid-Cap Dividend Stocks Answering The Call
- 7 Dividend Stocks To Take The Emotion Out Of Investing
- A Winning Investment Strategy
- 7 Dividend Stocks To Slay The Wall Street Giants
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.